SEC 13F Intelligence

Primecap Management Co/Ca/ / BMRN

Primecap Management Co/Ca/’s Biomarin Pharmaceutical Inc Position

Does Primecap Management Co/Ca/ own Biomarin Pharmaceutical Inc (BMRN)? Yes — 14.19M shares worth $802M (+0.63% of its 13F portfolio) as of Q1 2026, down from 14.55M shares the prior filed quarter.

Position Value
$802M
Q1 2026
Shares
14.19M
% of Portfolio
+0.63%
Quarters Held
30
currently held

Position History BMRN

Reported value by quarter
Q4 ’18: $1.2BQ4 ’18Q1 ’19: $1.3BQ2 ’19: $1.2BQ3 ’19: $1.0BQ4 ’19: $1.4BQ4 ’19Q1 ’20: $1.5BQ2 ’20: $2.2BQ3 ’20: $1.4BQ4 ’20: $1.6BQ4 ’20Q1 ’21: $1.4BQ2 ’21: $1.5BQ3 ’21: $1.4BQ4 ’21: $1.6BQ4 ’21Q1 ’22: $1.4BQ2 ’22: $1.5BQ3 ’22: $1.5BQ4 ’22: $1.8BQ4 ’22Q1 ’23: $1.8BQ2 ’23: $1.6BQ3 ’23: $1.6BQ4 ’23: $1.8BQ4 ’23Q1 ’24: $1.6BQ2 ’24: $1.5BQ3 ’24: $1.3BQ4 ’24: $1.2BQ4 ’24Q1 ’25: $1.3BQ2 ’25: $867MQ3 ’25: $825MQ4 ’25: $865MQ4 ’25Q1 ’26: $802Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202614.19M$802M+0.63%
Q4 202514.55M$865M+0.65%
Q3 202515.23M$825M+0.63%
Q2 202515.77M$867M+0.69%
Q1 202517.77M$1.3B+1.04%
Q4 202418.19M$1.2B+0.93%
Q3 202418.87M$1.3B+0.98%
Q2 202418.79M$1.5B+1.12%
Q1 202418.71M$1.6B+1.22%
Q4 202318.41M$1.8B+1.41%
Q3 202318.41M$1.6B+1.37%
Q2 202318.38M$1.6B+1.33%
Q1 202318.24M$1.8B+1.55%
Q4 202217.58M$1.8B+1.67%
Q3 202217.63M$1.5B+1.45%
Q2 202217.68M$1.5B+1.31%
Q1 202217.78M$1.4B+1.03%
Q4 202117.80M$1.6B+1.09%
Q3 202117.94M$1.4B+0.98%
Q2 202117.95M$1.5B+1.01%
Q1 202118.16M$1.4B+0.96%
Q4 202018.15M$1.6B+1.18%
Q3 202018.19M$1.4B+1.14%
Q2 202017.88M$2.2B+1.89%
Q1 202017.81M$1.5B+1.48%
Q4 201916.33M$1.4B+1.00%
Q3 201915.16M$1.0B+0.82%
Q2 201914.28M$1.2B+0.90%
Q1 201914.19M$1.3B+0.93%
Q4 201814.19M$1.2B+0.98%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Primecap Management Co/Ca/’s full portfolio or all institutional holders of BMRN.